CITIUS ONCOLOGY INC
CTOR · NASDAQ
更新於 2026-10-14 09:20:46
- 今日最高
- $0.84
- 今日最低
- $0.74
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $0.85
- 昨天收盤價
- $0.81
- 成交量
- 67.95K
- 市值
- $75.55M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.47
昨天價格區間
52週價格區間
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 藥品製造商 - 專科及仿製藥
- 總部
- 11 COMMERCE DRIVE, CRANFORD, NJ, UNITED STATES, 07016
- 國家
- 美國
- 上市日期
- 2022-10-14
- 財年截止
- 九月
- 流通股數
- 92.98M
- CIK
- 0001851484
- 官方網址
- citiusonc.com
Citius Oncology, Inc. 是一家臨床階段生物製藥公司，專注於為服務不足的患者群體開發創新癌症療法。憑藉強大的專有技術管線，Citius 旨在提高多種癌症適應症的治療療效和安全性。公司正通過關鍵性臨床試驗和監管流程戰略性地推進其有前景的候選藥物，並利用合作夥伴關係和嚴格的臨床研究標準來優化患者 outcomes，滿足腫瘤領域的 critical 需求。
財務指標
營業收入
2026-06-30
$1.49M
2026-03-31
$1.66M
2025-12-31
$3.94M
2025-09-30
$0
營業支出
2026-06-30
$7.99M
2026-03-31
$29.95M
2025-12-31
$8.4M
2025-09-30
$4.71M
淨利潤
2026-06-30
-$8.92M
2026-03-31
-$26.6M
2025-12-31
-$5.53M
2025-09-30
-$4.99M
淨利潤率
2026-06-30
-597.39%
2026-03-31
-1.59K%
2025-12-31
-140.31%
2025-09-30
--
每股收益
2026-06-30
$-0.08
2026-03-31
$-0.27
2025-12-31
$-0.06
2025-09-30
$-0.06
息稅折舊攤銷前利潤
2026-06-30
-$6.99M
2026-03-31
-$26.8M
2025-12-31
-$4.65M
2025-09-30
-$4.67M
有效稅率
2026-06-30
1.18%
2026-03-31
0.86%
2025-12-31
-5.01%
2025-09-30
-5.58%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $1.49M | $1.66M | $3.94M | $0 |
| 營業支出 | $7.99M | $29.95M | $8.4M | $4.71M |
| 淨利潤 | -$8.92M | -$26.6M | -$5.53M | -$4.99M |
| 淨利潤率 | -597.39% | -1.59K% | -140.31% | -- |
| 每股收益 | $-0.08 | $-0.27 | $-0.06 | $-0.06 |
| 息稅折舊攤銷前利潤 | -$6.99M | -$26.8M | -$4.65M | -$4.67M |
| 有效稅率 | 1.18% | 0.86% | -5.01% | -5.58% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。